Fermicon 7/Somnugen (Canada)

This page contains information on Fermicon 7/Somnugen for veterinary use.
The information provided typically includes the following:

Fermicon 7/Somnugen Indications
Warnings and cautions for Fermicon 7/Somnugen
Direction and dosage information for Fermicon 7/Somnugen

Fermicon 7/somnugen

This treatment applies to the following species:

Manufacturer: Boehringer

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Haemophilus Somnus Bacterin-Toxoid

Veterinary Use Only

Fermicon 7/Somnugen Indications

For the vaccination of healthy, susceptible cattle as an aid in the reduction of diseases caused by Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, and Cl. perfringens Types C and D, and as an aid in the prevention of disease caused by Haemophilus somnus.

Dosage

Using aseptic technique, inject 5 mL intramuscularly or subcutaneously. Repeat in 21 to 28 days and once annually.

Fermicon 7/Somnugen Caution

Store in dark at 2-7°C. Avoid freezing. Shake well. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur. Antidote: Epinephrine.

Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.S. Veterinary License No. 124

Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4

10 Doses/50 mL	18707-04
50 Doses/250 mL	18708-04
200 Doses/1000 mL	18736-03

Nac No.

12300202

BOEHRINGER INGELHEIM (CANADA) LTD.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4

Telephone:		905-639-0333
Customer Service:		800-567-1885
Fax:		905-681-0194
Website:		www.boehringer-ingelheim.ca

Every effort has been made to ensure the accuracy of the Fermicon 7/Somnugen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Printable Version

Email Page